Lindsay Nahmiache - Mednow Member Advisor

MDNWF Stock  USD 0.02  0.00  0.00%   

Insider

Lindsay Nahmiache is Member Advisor of Mednow Inc
Phone855-686-6300
Webhttps://www.mednow.ca

Mednow Management Efficiency

The company has return on total asset (ROA) of (0.5537) % which means that it has lost $0.5537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.897) %, meaning that it generated substantial loss on money invested by shareholders. Mednow's management efficiency ratios could be used to measure how well Mednow manages its routine affairs as well as how well it operates its assets and liabilities.
Mednow Inc has accumulated 30 K in total debt with debt to equity ratio (D/E) of 0.28, which may suggest the company is not taking enough advantage from borrowing. Mednow Inc has a current ratio of 1.79, which is within standard range for the sector. Debt can assist Mednow until it has trouble settling it off, either with new capital or with free cash flow. So, Mednow's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mednow Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mednow to invest in growth at high rates of return. When we think about Mednow's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Perry GoldDoximity
N/A
Jim RivasDoximity
N/A
Marshall MohrVeeva Systems Class
65
Priscilla HungVeeva Systems Class
53
Itaru TanimuraM3 Inc
58
Ato GarrettVeeva Systems Class
N/A
Tyson MurdockHealthEquity
53
Timothy MRCPM3 Inc
N/A
Mary HedleyVeeva Systems Class
56
Tina HuntVeeva Systems Class
53
E ZuppasVeeva Systems Class
50
Pinal PatelVeeva Systems Class
N/A
Nate GrossDoximity
N/A
Shari BuckDoximity
N/A
Nate MDDoximity
40
Paul RiceM3 Inc
N/A
Paul JorgensenDoximity
53
Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Mednow is traded on OTC Exchange in the United States. Mednow Inc [MDNWF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Mednow Inc Leadership Team

Elected by the shareholders, the Mednow's board of directors comprises two types of representatives: Mednow inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mednow. The board's role is to monitor Mednow's management team and ensure that shareholders' interests are well served. Mednow's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mednow's outside directors are responsible for providing unbiased perspectives on the board's policies.
CMA CPA, Chief Officer
Felipe RPh, Treasurer, CoFounder
Simranveer Grewal, VP Technology
Amir RPh, CEO CoFounder
Anthony Perlman, VP Strategy
Dave Marantz, Chief Officer
Lindsay Nahmiache, Member Advisor

Mednow Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Mednow a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Mednow Pink Sheet

Mednow financial ratios help investors to determine whether Mednow Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mednow with respect to the benefits of owning Mednow security.